NCT00207298View on ClinicalTrials.gov

18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology

CompletedOBSERVATIONAL
Enrollment

39,242

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Brain NeoplasmsLung NeoplasmsLymphomaMelanomaColorectal Neoplasms
Interventions
PROCEDURE

Positron Emission Tomography

Each patient will receive an 18F-FDG PET/CT scan

Trial Locations (1)

V5Z 4E6

BCCA, Vancouver Centre, Vancouver

All Listed Sponsors
lead

British Columbia Cancer Agency

OTHER

NCT00207298 - 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology | Biotech Hunter | Biotech Hunter